Dmitri Pavlov

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Antoni Ribas, Richard Kefford, Margaret Marshall et al. · Journal of Clinical Oncology · 2013 · 815 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

Nancy Y. Lee, Robert L. Ferris, Amanda Psyrri et al. · The Lancet Oncology · 2021 · 617 citations

Medicine, Oncology, Radiation Oncology +8

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas, Luis H. Camacho, Gabriel Lopez‐Berestein et al. · Journal of Clinical Oncology · 2005 · 584 citations

Medicine, Oncology, Pharmacology +17

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma

Luis H. Camacho, Scott Antonia, Jeffrey A. Sosman et al. · Journal of Clinical Oncology · 2009 · 314 citations

Pharmacy, Oncology, Pharmacotherapy +17

Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial

Brian I. Rini, Bohuslav Melichar, Takeshi Ueda et al. · The Lancet Oncology · 2013 · 232 citations · Full text

Medicine, Oncology, Pharmacology +11